CTN-0031: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
Dennis M. Donovan, PhD
Co-Lead Investigator
Director, Alcohol and Drug Abuse Institute
University of Washington
ddonovan@u.washington.edu
Dennis Daley, PhD
Co-Lead Investigator
Chief, Addiction Medicine Services
Western Psychiatric Institute and Clinic
daleydc@upmc.edu
The primary objective of this protocol is to evaluate the degree to which a combined group and individual 12-Step facilitative intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers. For this protocol, STAGE-12 will be integrated into treatment as usual. The primary objective is to evaluate reduction in percent of days of stimulant use as measured by self-report. This is a randomized, 2-group design comparing STAGE-12 integrated into TAU (STAGE-12 /TAU) to TAU without STAGE-12 for stimulant abusers receiving formal substance abuse treatment in participating community-based treatment programs (CTP). A total of approximately 450 stimulant users seeking formal treatment, recruited from 10 CTPS, will be randomized.
Primary Findings
Findings were mixed with respect to the impact of integrating the STAGE-12 intervention into intensive outpatient drug treatment compared with treatment as usual on stimulant drug use. However, the results more clearly indicate that individuals in STAGE-12 had higher rates of 12-step meeting attendance and were engaged in more related activities throughout both the active treatment phase and the entire 6-month follow-up period than did those in treatment as usual.
Primary Outcomes Article: Donovan DM, et al. Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): A Multisite Trial in the National Institute on Drug Abuse Clinical Trials Network. Journal of Substance Abuse Treatment 2012;44(1):103-114. [get article]
Related Studies
- CTN-0031-A-1: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Ancillary Investigation
- CTN-0031-A-2: The Role of Alcohol Consumption in Classifications of Alcohol Use Disorders: A Clinical Study
- CTN-0031-A-3: Organizational Characteristics that Influence the Adoption of Evidence-Based Practices
Related Resources
- CTN-0031 Study Protocol
- Publications in the Library about CTN-0031
- Study data from NIDA Data Share
- Study Manual: Baker S, et al. STAGE-12: Stimulant Abuser Groups to Engage in 12-Step Programs: A Combined Group and Individual Treatment Program, v.3.0. Manual developed for National Drug Abuse Treatment Clinical Trials Network protocol CTN-0031, April 2009, 139 p.
- ClinicalTrials.gov (NCT00573183)
- NIDA protocol page
Node Involvement
Lead Node(s):
All Participating Nodes: